Comparison
Magnesium L-Threonate vs CBD (Cannabidiol)
Magnesium L-Threonate
MIT-developed magnesium that crosses the blood-brain barrier. Shown to enhance synaptic density and reduce 'brain age'.
CBD (Cannabidiol)
Non-psychoactive cannabinoid from hemp. Anxiolytic, anti-seizure, anti-inflammatory. The supplement market has grown explosively despite mixed evidence base.
| Field | Magnesium L-Threonate | CBD (Cannabidiol) |
|---|---|---|
| Category | neuroprotective | neuroprotective |
| Dose range | 1000–2000mg | 25–600mg |
| Half-life | 6h | — |
| Onset | — | — |
| Evidence | EVIDENCEB | EVIDENCEB |
| Safety | ●●●●● | ●●●●○ |
| Legal (US) | USOTC | USOTC |
| PubMed refs | 90 | 6800 |
The comparison in plain English
Auto-generated from dataMagnesium L-Threonate and CBD (Cannabidiol) are both in the neuroprotective category respectively. Magnesium L-Threonate MIT-developed magnesium that crosses the blood-brain barrier. CBD (Cannabidiol) Non-psychoactive cannabinoid from hemp.
Bottom line
Magnesium L-Threonate (evidence B, safety 5/5) matches the evidence base of CBD (Cannabidiol) (evidence B, safety 4/5). Magnesium L-Threonate has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose Magnesium L-Threonate if
Magnesium L-Threonate is the better fit when your goal aligns with its mechanism (L-threonate is a sugar-acid carrier that uniquely enables magnesium to cross the blood-brain barrier in meaningful quantities — most oral magnesium forms (oxide, citrate, glycinate) raise serum magnesium but not central magnesium) and the dose range (1000–2000mg) suits your protocol. Half-life is 6h.
Choose CBD (Cannabidiol) if
CBD (Cannabidiol) is the better fit when your goal aligns with its mechanism (Modulates the endocannabinoid system through indirect mechanisms — CBD doesn't bind CB1 or CB2 receptors directly like THC does) and the dose range (25–600mg) suits your protocol. Half-life is —h.